There’s a growing realization that advances in connected devices, sensors and predictive analytics represent a game-changer when it comes to patient support programs (PSPs), writes Jim O'Donaghue.
Jim O’Donoghue
Advertisement
Jim O’Donoghue is head of S3 Connected Health, headquartered in Dublin, Ireland. He has 30 years’ experience in designing and delivering innovative services and solutions across healthcare, consumer and communications sectors.Over the past 15 years Jim and his team have designed digital patient support solutions for Pharma and Healthcare Providers that are available across 40 countries, including the largest telehealth program in the UK, and the largest chronic disease management program in Europe.
Articles by Jim O’Donoghue
With less than 50% of patients with long-term conditions remaining adherent to their recommended treatment, we need to look to behavioral science to deconstruct the barriers that make people act in ways that can seem self-defeating, writes Jim O'Donaghue.
Advertisement
Latest Updated Articles
Patient Adherence and Human NaturePublished: April 15th 2018 | Updated:
Next-Gen Patient Support Programs Gain Momentum in the Quest for ValuePublished: September 20th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
How Will the Inclusion of GLP-1s in Medicaid and Medicare Impact Businesses?
5
